Overview

Healthcare Contract Research Organization (CRO) Market is poised to value over USD 64.3 billion by 2028 end at a CAGR of over 6.8% during the forecast period 2021 to 2028

FutureWise Market Research has instantiated a report that provides an intricate analysis of Healthcare Contract Research Organization (CRO) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Healthcare Contract Research Organization (CRO) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Healthcare Contract Research Organization (CRO) Market:
• IQVIA
• Covance Inc.
• Pharmaceutical Product Development, LLC (PPD)
• PAREXEL
• Charles River Laboratories
• ICON, plc.
• Medidata Solutions, Inc.
• Syneos Health.
• Pharmaron.
• GVK Biosciences Private Limited.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Healthcare Contract Research Organization (CRO) Market Segmentation:
By Type
• Drug Discovery
 o Target validation
 o Lead identification
 o Lead optimization
• Pre-Clinical
• Clinical
 o Phase I Trial Services
 o Phase II Trial Services
 o Phase III Trial Services
 o Phase IV Trial Services
By Service
• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient and site Recruitment
• Technology
• Others
By Therapeutic Area
• Oncology
• Infectious Diseases 
• CVS Disorders 
• Neurology
• Vaccines
• Respiratory Disorders 
• Ophthalmology 
• Hematology
• Gastrointestinal Disease
• Other Therapeutic Areas
By End User
• Pharma & biopharma companies
• Medical Device Companies
• Research Institutes
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Healthcare Contract Research Organization (CRO) Market By Type, By Service, By Therapeutic Area, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Application launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Healthcare Contract Research Organization (CRO) Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Healthcare Contract Research Organization (CRO) Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Healthcare Contract Research Organization (CRO) Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Healthcare Contract Research Organization (CRO) Market, By Type Historical Analysis and Forecast 2021-2028 (USD Million)
   7.1. Drug Discovery
        7.1.1. Target validation
        7.1.2. Lead identification
        7.1.3. Lead optimization
   7.2. Pre-Clinical
   7.3. Clinical
        7.3.1. Phase I Trial Services
        7.3.2. Phase II Trial Services
        7.3.3. Phase III Trial Services
        7.3.4. Phase IV Trial Services

8. Healthcare Contract Research Organization (CRO) Market, By Service Historical Analysis and Forecast 2021-2028 (USD Million)  
   8.1. Project Management/Clinical Supply Management
   8.2. Data Management
   8.3. Regulatory/Medical Affairs
   8.4. Medical Writing
   8.5. Clinical Monitoring
   8.6. Quality Management/ Assurance
   8.7. Bio-statistics
   8.8. Investigator Payments
   8.9. Laboratory
   8.10. Patient and site Recruitment
   8.11. Technology
   8.12. Others

9. Healthcare Contract Research Organization (CRO) Market, By Therapeutic Area Historical Analysis and Forecast 2021-2028 (USD Million)  
   9.1. Oncology
   9.2. Infectious Diseases 
   9.3. CVS Disorders 
   9.4. Neurology
   9.5. Vaccines
   9.6. Respiratory Disorders 
   9.7. Ophthalmology 
   9.8. Hematology
   9.9. Gastrointestinal Disease
   9.10. Other Therapeutic Areas

10. Healthcare Contract Research Organization (CRO) Market, By End User Historical Analysis and Forecast 2021-2028 (USD Million)  
    10.1. Pharma & biopharma companies
    10.2. Medical Device Companies
    10.3. Research Institutes

11. North America Healthcare Contract Research Organization (CRO) Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. U.S.A
          11.2.2. Canada
          11.2.3. Mexico
    11.3. Market Size (USD Million) Forecast for North America 2021-2028

12. Latin America Healthcare Contract Research Organization (CRO) Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Brazil
          12.2.2. Venezuela
          12.2.3. Argentina
          12.2.4. Rest of Latin America
    12.3. Market Size (USD Million) Forecast for Latin America 2021-2028

13. Europe Healthcare Contract Research Organization (CRO) Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Germany
          13.2.2. U.K         
          13.2.3. France
          13.2.4. Italy
          13.2.5. Spain
          13.2.6. Russia
          13.2.7. Poland
          13.2.8. Rest of Europe
    13.3. Market Size (USD Million) Forecast for Europe 2021-2028

14. Asia Pacific Healthcare Contract Research Organization (CRO) Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. Japan
          14.2.2. China
          14.2.3. India
          14.2.4. Australia and New Zealand
          14.2.5. ASEAN
          14.2.6. Rest of Asia Pacific
    14.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028  

15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Saudi Arabia
          15.2.2. UAE
          15.2.3. South Africa
          15.2.4. Egypt
    15.3. Market Size (USD Million) Forecast for MEA 2021-2028

16. Market Share Analysis and Competitive Landscape   
    16.1. Global Landscape - Key Players, Revenue and Presence
    16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    16.3. Global Emerging Companies
    16.4. North America - Market Share Analysis and Key Regional Players
    16.5. Europe - Market Share Analysis and Key Regional Players
    16.6. Asia Pacific - Market Share Analysis and Key Regional Players
    16.7. Global Key Player - Growth Matrix

17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    17.1. IQVIA
          17.1.1. Company Overview
          17.1.2. Product Portfolio
          17.1.3. SWOT Analysis
          17.1.4. Financial Overview
          17.1.5. Strategic Overview
    17.2. Covance Inc.
          17.2.1. Company Overview
          17.2.2. Product Portfolio
          17.2.3. SWOT Analysis
          17.2.4. Financial Overview
          17.2.5. Strategic Overview 
    17.3. Pharmaceutical Product Development, LLC (PPD)
          17.3.1. Company Overview
          17.3.2. Product Portfolio
          17.3.3. SWOT Analysis
          17.3.4. Financial Overview
          17.3.5. Strategic Overview
    17.4. PAREXEL
          17.4.1. Company Overview
          17.4.2. Product Portfolio
          17.4.3. SWOT Analysis
          17.4.4. Financial Overview
          17.4.5. Strategic Overview
    17.5. Charles River Laboratories
          17.5.1. Company Overview
          17.5.2. Product Portfolio
          17.5.3. SWOT Analysis
          17.5.4. Financial Overview
          17.5.5. Strategic Overview          
    17.6. ICON, plc.
          17.6.1. Company Overview
          17.6.2. Product Portfolio
          17.6.3. SWOT Analysis
          17.6.4. Financial Overview
          17.6.5. Strategic Overview      
    17.7. Medidata Solutions, Inc.
          17.7.1. Company Overview
          17.7.2. Product Portfolio
          17.7.3. SWOT Analysis
          17.7.4. Financial Overview
          17.7.5. Strategic Overview
    17.8. Syneos Health
          17.8.1. Company Overview
          17.8.2. Product Portfolio
          17.8.3. SWOT Analysis
          17.8.4. Financial Overview
          17.8.5. Strategic Overview 
    17.9. Pharmaron
          17.9.1. Company Overview
          17.9.2. Product Portfolio
          17.9.3. SWOT Analysis
          17.9.4. Financial Overview
          17.9.5. Strategic Overview 
    17.10.GVK Biosciences Private Limited
          17.10.1. Company Overview
          17.10.2. Product Portfolio
          17.10.3. SWOT Analysis
          17.10.4. Financial Overview
          17.10.5. Strategic Overview

18. Pre and Post COVID-19 Impact
    18.1. Positive influence on the healthcare industry
    18.2. The financial disruption of the manufacturing sector
    18.3. Impact of COVID-19 on emerging companies
    18.4. Significant mandates in the healthcare regulations initiated by administrations
    18.5. The overall economic slowdown of the developing and developed nations

19. FutureWise SME Key Takeaway Points for Client

Tables

Figures